Outsourcing still a gamble that needs strategic vision to succeed, says study
Outsourcing is a gamble for the industry that needs a closer collaborative approach if pharma firms want a successful performance, according to new research.
Outsourcing is a gamble for the industry that needs a closer collaborative approach if pharma firms want a successful performance, according to new research.
Outsourcing-Pharma presents a roundup of eClinical technology news, including “omnics” at Oracle and DDi at DIA.
Granules India says Big Pharma demand for highly efficient manufacturing in era of patent loss helped it gain market share in Q3 fiscal 2012.
The FDA has followed the EMA in approving the Framingham, MA plant that Genzyme hopes will cut production bottlenecks.
Preclinical CROs begin reporting full year results this week, with talk of takeovers and toxicology high on agendas.
Sartorius Stedim Biotech (SSB) says its partnership with Refine Technology will help meet demand for greater connectivity between retention devices and bioreactors and save Pharmas time and money
UK-based ProTrials Research will expand a new subsidiary in a bid to meet its clients increasing demands for a wider range of multi-national clinical trials.